REGENERON PHARMACEUTICALS, INC. Taxes Payable, Current
REGENERON PHARMACEUTICALS, INC. (REGN) had Taxes Payable, Current of $351.30 million as of 2025-12-31, per its 10-K filed 2026-02-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2026-02-04
- 2025-12-31: Taxes Payable, Current $351.30M.
- 2024-12-31: Taxes Payable, Current $213.20M.
- 2023-12-31: Taxes Payable, Current $11.70M.
- 2022-12-31: Taxes Payable, Current $300.00K.
| Period end | Taxes Payable, Current | Taxes Payable, Current as first filed |
|---|---|---|
| 2025-12-31 | $351.30M 10-K · filed 2026-02-04 | |
| 2024-12-31 | $213.20M 10-K · filed 2026-02-04 | |
| 2023-12-31 | $11.70M 10-K · filed 2025-02-05 | |
| 2022-12-31 | $300.00K 10-K · filed 2023-02-06 | |
| 2021-12-31 | $326.30M 10-K · filed 2023-02-06 | |
| 2020-12-31 | $19.50M 10-K · filed 2022-02-07 | |
| 2019-12-31 | $49.40M 10-K · filed 2021-02-08 | |
| 2018-12-31 | $20.80M 10-K · filed 2020-02-07 | |
| 2017-12-31 | $200.00K 10-K · filed 2019-02-07 | $227.00K 10-K · filed 2018-02-08 |
| 2017-09-30 | $126.61M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $23.24M 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $450.81M 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $235.78M 10-K · filed 2018-02-08 | |
| 2016-09-30 | $155.49M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $170.27M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $144.08M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $0.00 10-K · filed 2017-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |